Folate tolerance varies Folic acid, folinic acid and methylfolate may help selected patients but may worsen anxiety, agitation or sleep in susceptible undermethylators

individual results vary significantly Both medications require adherence to dosing schedule and lifestyle modifications Higher doses generally produce better results but may have more side effects Not everyone reaches maximum doses due to side effect tolerance Actual weight loss depends on starting weight, diet, exercise, and individual metabolism Time to See Results: Semaglutide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (5-8 pounds) Weeks 12-24: Steady weight loss (1-2 pounds per week) Weeks 24-68: Continued weight loss at slower pace Tirzepatide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (8-12 pounds) Weeks 12-24: Steady weight loss (1.5-2.5 pounds per week) Weeks 24-72: Continued weight loss, often at sustained pace Both medications show continued weight loss throughout the clinical trial periods, with weight loss plateauing around month 16-20 for most participants

Further research will be crucial in defining the optimal use, safety, and full spectrum of benefits of this combination therapy in various populations
10.1016/0022-4731(76)90007-8 53 HeX.DongZ.CaoY.WangH.LiuS.LiaoL.et al (2019)
a review count this small means each individual review swings the score meaningfully, and the sample is too small to generalize from
Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus